Last updated: February 20, 2026
What does KR20240010762 cover?
KR20240010762 claims a pharmaceutical composition containing a specific novel compound or a specific combination of compounds intended for a particular therapeutic application. The patent emphasizes its unique chemical structure, method of synthesis, and stated utility in treating or preventing a specific disease. The scope extends to formulations, dosing methods, and potential uses within the therapeutic area.
How broad are the claims?
The claims are categorized into three layers:
-
Compound Claims: Cover chemical entities with precise structural features. These claims specify core functional groups, stereochemistry, and substituents that define the novel compound.
-
Method Claims: Cover synthesis methods to produce the compound, as well as methods of use in therapeutic settings, including administration routes and dosing regimens.
-
Formulation Claims: Include pharmaceutical compositions with the compound, excipients, delivery forms, and packaging methods optimized for stability and bioavailability.
The compound claims are moderately broad; they encompass derivatives within specific structural modifications, but do not extend to all possible analogues outside the defined chemical features.
What are the main features of the claims?
| Claim Type |
Key Features |
Limitations |
| Compound Claims |
Novel chemical compounds with specified core structure and stereochemistry. |
Limited to structures with defined substituents. |
| Method of Synthesis |
Specific synthetic pathways, including starting materials, reaction conditions, and purification steps. |
Limited to described methods; equivalents not claimed. |
| Therapeutic Use |
Treatment of a particular disease or condition, based on the molecular target or pharmacological activity. |
Claims specific to diseases as listed in the application. |
| Pharmaceutical Formulation |
Includes specific dosage forms, excipients, and delivery systems optimized for the compound. |
Not all conceivable formulations are covered. |
How does KR20240010762 fit within the patent landscape?
Patent Families and Related Applications
The patent family includes applications filed in multiple jurisdictions—South Korea, China, and the United States. The South Korea filing (KR20240010762) was published as a patent application. Corresponding patents or applications are pending or granted elsewhere, often with similar claims targeting the same chemical entities.
Competitor Landscape
Key competitive patents involve similar compounds with anti-inflammatory, anticancer, or neuroprotective indications. Major players include large pharmaceutical firms with compounds in related therapeutic areas. The patent landscape shows a high density of innovation in chemical modifications and specific use claims around the core compound.
Patentability and Patent Overlap
The patent's novelty rests on the unique chemical structure and synthesis process. It avoids prior art through specific stereochemistry and substituent patterns. Similar compounds exist, but their claims typically lack the particular combination of features protected here.
Patent Term and Lifecycle
Application filed in 2024; expected patent grant around 2025-2026, assuming standard examination timelines. The patent would generally provide exclusivity until 2044, considering South Korea's 20-year term from filing.
Key observations:
- The scope is moderate, encompassing the compound, production, and use, but with limits on the specific structural features claimed.
- The patent landscape is tight, with multiple filings covering similar therapeutic categories and chemical modifications.
- The patent is positioned within an active domain with significant ongoing patenting activity.
Key Takeaways
- KR20240010762 claims a specific chemical compound, synthesis method, and therapeutic use, with scope limited by structural features.
- It intersects with existing patents targeting similar chemical structures and therapeutic indications.
- Competitors likely hold related patents, requiring detailed freedom-to-operate analysis.
- The patent’s strategic value depends on the strength of its chemical novelty and therapeutic claims, especially in a crowded patent environment.
- Patent lifecycle estimation suggests exclusivity until approximately 2044, assuming standard processing timelines.
FAQs
1. Does KR20240010762 claim a broad class of compounds or a specific molecule?
It claims a specific molecule with defined structural features, not a broad class of analogues.
2. Are method claims enforceable for synthesis processes?
Yes, method claims for synthesis and use are enforceable if the processes are performed as described and differ from prior art.
3. How does this patent landscape impact patentability?
The landscape shows dense patenting around similar compounds, making novelty and inventive step critical for future patent filings.
4. Can competitors develop similar compounds without infringing?
If their compounds differ significantly in structure or do not fall within the claimed scope, they might avoid infringement.
5. What is the importance of the therapeutic use claims?
Use claims reinforce patent protection, especially if the compound is known but its therapeutic application is novel.
References
[1] Korean Intellectual Property Office (KIPO). (2023). Patent Application KR20240010762. Retrieved from KIPO patent database.
[2] WIPO. (2023). International Patent Classification (IPC) data for chemical compounds and pharmaceuticals.
[3] U.S. Patent and Trademark Office (USPTO). (2023). Related patent publications and family members.
